# RAMIE Versus MIE for Resectable Esophageal Cancer, a Randomized Controlled Trial (ROBOT-2 Trial).

> **NCT04306458** · NA · RECRUITING · sponsor: **University Medical Center Mainz** · enrollment: 218 (estimated)

## Conditions studied

- Esophageal Adenocarcinoma

## Interventions

- **PROCEDURE:** Minimally invasive esophagectomy
- **DEVICE:** daVinci Xi system

## Key facts

- **NCT ID:** NCT04306458
- **Lead sponsor:** University Medical Center Mainz
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-01-18
- **Primary completion:** 2023-05-19
- **Final completion:** 2028-01-19
- **Target enrollment:** 218 (ESTIMATED)
- **Last updated:** 2022-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04306458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04306458, "RAMIE Versus MIE for Resectable Esophageal Cancer, a Randomized Controlled Trial (ROBOT-2 Trial).". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04306458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*